Sign in to continue reading this article

Not registered? Create an account for free to read full articles on

To access full articles on, please sign in below.

Busy? Sign in Faster. Sign into with your social media account.

This pilot study aimed to evaluate the 6-minute walk test (6MWT) and a pedometer as noninvasive measures of ambulatory capacity using Labrador retrievers with centronuclear myopathy (CNM) as a model of generalized neuromuscular disease.

Eight purpose-bred littermates (3 affected, 2 carrier, and 3 unaffected) were tested. The dogs were acclimated to the testing area before the study and were repeatedly tested between 9 to 50 weeks of age. The animals were allowed to walk at their own pace for 6 minutes, and distance and pedometer readings were recorded. As affected dogs aged, they developed progressively more severe paresis and exercise intolerance, cervical ventroflexion, and a persistently kyphotic posture.

One of the normal/carrier dogs was unable to complete the 6MWT, but this was determined to be because of behavior rather than exercise intolerance. Two of 3 affected dogs were unable to complete the test because of severe exercise intolerance. Pedometer readings for affected dogs did not differ from those for unaffected/carrier dogs. This was attributed to affected dogs taking a larger number of short-stride steps but covering less distance than unaffected littermates.

The authors concluded that the 6MWT could differentiate between normal and CNM-affected dogs. However, pedometers did not appear to accurately assess exercise intolerance in CNM-affected dogs.

References Show


Cerda-Gonzalez S, Talarico L, Todhunter R. Noninvasive assessment of neuromuscular disease in dogs: use of the 6-minute walk test to assess submaximal exercise tolerance in dogs with centronuclear myopathy. J Vet Intern Med. 2016;30(3):808-812.

Material from Clinician’s Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Up Next